PTPRC and neoplasm: Flow cytometry analysis, carried out 28 days after implanting the cells, confirmed a pervasive macrophage infiltration into the orthotopic tumors (OT) (3.2% of total CD45+ cells compared with 0.4% in sham-operated non-tumor bearing controls) (Figure 1a, Figure S1a).